These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 26970307)
1. Pre-clinical assessment of A-674563 as an anti-melanoma agent. Zou Y; Fan G; Wang X Biochem Biophys Res Commun; 2016 Aug; 477(1):1-8. PubMed ID: 26970307 [TBL] [Abstract][Full Text] [Related]
2. AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms. Zhang S; Deng Z; Yao C; Huang P; Zhang Y; Cao S; Li X PLoS One; 2017; 12(1):e0169585. PubMed ID: 28081222 [TBL] [Abstract][Full Text] [Related]
3. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells. Xu L; Zhang Y; Gao M; Wang G; Fu Y Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060 [TBL] [Abstract][Full Text] [Related]
4. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway. Yao X; Jiang W; Yu D; Yan Z Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726 [TBL] [Abstract][Full Text] [Related]
5. Taraxasterol attenuates melanoma progression via inactivation of reactive oxygen species-mediated PI3K/Akt signaling pathway. Liu W; Yu Q; Wang F; Li Y; Zhang G; Tao S Hum Exp Toxicol; 2022; 41():9603271211069034. PubMed ID: 35128947 [No Abstract] [Full Text] [Related]
6. AMPK activation by GSK621 inhibits human melanoma cells in vitro and in vivo. Chen L; Chen Q; Deng G; Kuang S; Lian J; Wang M; Zhu H Biochem Biophys Res Commun; 2016 Nov; 480(4):515-521. PubMed ID: 27751856 [TBL] [Abstract][Full Text] [Related]
7. C6 ceramide motivates the anticancer sensibility induced by PKC412 in preclinical head and neck squamous cell carcinoma models. Zhu Y; Wang C; Zhou Y; Ma N; Zhou J J Cell Physiol; 2018 Dec; 233(12):9437-9446. PubMed ID: 29968910 [TBL] [Abstract][Full Text] [Related]
8. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib. Graziani G; Artuso S; De Luca A; Muzi A; Rotili D; Scimeca M; Atzori MG; Ceci C; Mai A; Leonetti C; Levati L; Bonanno E; Tentori L; Caccuri AM Biochem Pharmacol; 2015 May; 95(1):16-27. PubMed ID: 25795251 [TBL] [Abstract][Full Text] [Related]
9. VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo. Shao Z; Bao Q; Jiang F; Qian H; Fang Q; Hu X PLoS One; 2015; 10(7):e0132655. PubMed ID: 26204252 [TBL] [Abstract][Full Text] [Related]
10. Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo. Zou Y; Ge M; Wang X Biochem Biophys Res Commun; 2017 Aug; 490(2):385-392. PubMed ID: 28623128 [TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent. Lv H; Zhang Z; Wu X; Wang Y; Li C; Gong W; Gui L; Wang X PLoS One; 2016; 11(1):e0145195. PubMed ID: 26727592 [TBL] [Abstract][Full Text] [Related]
12. Increasing ceramides sensitizes genistein-induced melanoma cell apoptosis and growth inhibition. Ji C; Yang YL; He L; Gu B; Xia JP; Sun WL; Su ZL; Chen B; Bi ZG Biochem Biophys Res Commun; 2012 May; 421(3):462-7. PubMed ID: 22507982 [TBL] [Abstract][Full Text] [Related]
13. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells. Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells. Mijatovic S; Maksimovic-Ivanic D; Mojic M; Timotijevic G; Miljkovic D; Mangano K; Donia M; Di Cataldo A; Al-Abed Y; Cheng KF; Stosic-Grujicic S; Nicoletti F J Cell Physiol; 2011 Jul; 226(7):1803-12. PubMed ID: 21506111 [TBL] [Abstract][Full Text] [Related]
15. The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells. Zhang Y; Liu H; Jin J; Zhu X; Lu L; Jiang H Anticancer Drugs; 2010 Jun; 21(5):494-501. PubMed ID: 20124987 [TBL] [Abstract][Full Text] [Related]
16. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways. Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920 [TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway]. Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997 [TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of perifosine as a potential promising anti-rhabdomyosarcoma agent. Shen J; Hong Y; Zhao Q; Zhang JL Tumour Biol; 2016 Jan; 37(1):1025-33. PubMed ID: 26269112 [TBL] [Abstract][Full Text] [Related]
19. Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells. Jiang F; Jin K; Huang S; Bao Q; Shao Z; Hu X; Ye J PLoS One; 2016; 11(9):e0159849. PubMed ID: 27631768 [TBL] [Abstract][Full Text] [Related]